EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

NYSE:ESRT • US2921041065

5.97 USD
-0.09 (-1.49%)
Last: Feb 20, 2026, 01:32 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ESRT. ESRT was compared to 123 industry peers in the Diversified REITs industry. Both the profitability and the financial health of ESRT get a neutral evaluation. Nothing too spectacular is happening here. ESRT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ESRT had positive earnings in the past year.
  • In the past year ESRT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ESRT reported negative net income in multiple years.
  • Of the past 5 years ESRT 4 years had a positive operating cash flow.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • ESRT has a Return On Assets (0.85%) which is comparable to the rest of the industry.
  • ESRT has a Return On Equity (3.25%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of ESRT (2.87%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.06%.
  • The last Return On Invested Capital (2.87%) for ESRT is above the 3 year average (2.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • With a Profit Margin value of 4.55%, ESRT perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ESRT has declined.
  • ESRT's Operating Margin of 18.68% is in line compared to the rest of the industry. ESRT outperforms 43.90% of its industry peers.
  • In the last couple of years the Operating Margin of ESRT has remained more or less at the same level.
  • ESRT has a worse Gross Margin (54.04%) than 73.17% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ESRT is destroying value.
  • There is no outstanding debt for ESRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.57, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
  • ESRT has a Altman-Z score (0.57) which is comparable to the rest of the industry.
  • ESRT has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • ESRT has a Debt to Equity ratio of 1.92. This is in the lower half of the industry: ESRT underperforms 68.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACC0.49
WACC5.92%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ESRT (2.59) is better than 91.87% of its industry peers.
  • A Quick Ratio of 2.59 indicates that ESRT has no problem at all paying its short term obligations.
  • ESRT has a better Quick ratio (2.59) than 91.87% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.10%, which is quite impressive.
  • ESRT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.42% yearly.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.96%

3.2 Future

  • The Earnings Per Share is expected to decrease by -39.35% on average over the next years. This is quite bad
  • ESRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.24% yearly.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.86, the valuation of ESRT can be described as very cheap.
  • 95.94% of the companies in the same industry are more expensive than ESRT, based on the Price/Earnings ratio.
  • ESRT is valuated cheaply when we compare the Price/Earnings ratio to 27.09, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 97.55, which means the current valuation is very expensive for ESRT.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ESRT.
  • ESRT is valuated expensively when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.86
Fwd PE 97.55
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaper than 92.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.82
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -61.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.25%. Purely for dividend investing, there may be better candidates out there.
  • With a Dividend Yield of 2.25, ESRT pays less dividend than the industry average, which is at 6.78. 83.74% of the companies listed in the same industry pay a better dividend than ESRT!
  • Compared to an average S&P500 Dividend Yield of 1.85, ESRT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • 79.65% of the earnings are spent on dividend by ESRT. This is not a sustainable payout ratio.
  • ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (2/20/2026, 1:32:05 PM)

5.97

-0.09 (-1.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners100.46%
Inst Owner Change6.57%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.02B
Revenue(TTM)N/A
Net Income(TTM)34.89M
Analysts75
Price Target8.12 (36.01%)
Short Float %3.87%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.01%
PT rev (3m)-10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.86
Fwd PE 97.55
P/S 1.33
P/FCF N/A
P/OCF 3.83
P/B 0.95
P/tB 3.7
EV/EBITDA 8.82
EPS(TTM)0.87
EY14.57%
EPS(NY)0.06
Fwd EY1.03%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY26.1%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)0.12
Graham Number11.11
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.57
F-Score6
WACC5.92%
ROIC/WACC0.49
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 6.86 and the Price/Book (PB) ratio is 0.95.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.